BioGeneration Ventures is a private equity general partner firm headquartered in Naarden, Netherlands.
EIF has invested in BioGeneration Ventures' third fund.
Netherlands-based life sciences company Cristal Therapeutics has raised $12.8m from Aglaia BioMedical Ventures and others.
Dutch needle-free vaccine developer Mucosis has secured €5.7m in funding from BioGeneration Ventures and others.
Read more news concerning BioGeneration Ventures
A sampling of BioGeneration Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?